Embolization of giant renal angiomyolipomas: technique and results

Journal of Vascular and Interventional Radiology : JVIR
Vivian L BishayS William Stavropoulos

Abstract

To evaluate the efficacy and safety of prophylactic embolization of angiomyolipomas (AMLs) larger than 10 cm. Sixteen patients (mean age, 41.2 years; 14 women and two men) underwent embolization for 23 AMLs larger than 10 cm. All lesions were embolized by using microcatheters with ethanol and ethiodized oil mixed to a ratio of 7(ethanol) to 3(ethiodized oil). Data collected included pre- and posttreatment AML size, creatinine level, technical success, volume of embolic material used, clinical success, and complications. The mean AML size before treatment was 15 cm (range, 10-25 cm). Ten of the 16 patients (62%) had all their AMLs treated in one session, whereas six (38%) required multiple sessions. A mean volume of 8.6 mL of the ethanol-ethiodized oil mixture (range, 2-20 mL) was administered per lesion. Patients were followed up for a mean of 29 months (range, 1-80 months). No patient had an increase of 0.2 mg/dL (17.7 mumol/L) or greater in mean serum creatinine level during the follow-up period. Two of the 16 patients (12%) required repeat embolization due to AML regrowth (n = 1) or reperfusion (n = 1) seen at surveillance imaging. One of the 16 patients (6.2%) had an AML hemorrhage 59 months after AML embolization. Emboliza...Continue Reading

References

Jun 1, 1986·The Journal of Urology·J E OesterlingF F Marshall
Oct 1, 1969·The Journal of Urology·S I Hajdu, F W Foote
Sep 1, 1984·Investigative Radiology·B A EllmanP C Peters
Jul 1, 1994·Journal of Vascular and Interventional Radiology : JVIR·M C SoulenC Cope
May 1, 1994·Australasian Radiology·P CorrI Tan
Dec 1, 1993·The Journal of Urology·M S SteinerF F Marshall
Apr 16, 1998·Journal of Vascular and Interventional Radiology : JVIR·W LeeJ H Park
May 1, 1998·Urologia Internationalis·D KehagiasL Vlahos
Feb 15, 2000·International Urology and Nephrology·D KehagiasL Vlahos
May 24, 2001·Archives of Pathology & Laboratory Medicine·C H StoneR J Zarbo
Apr 23, 2002·Australasian Radiology·Samuel D AshebuHana Al-Khawari
Dec 11, 2003·The Journal of Urology·Toru HarabayashiTomohiko Koyanagi
Aug 18, 2005·Journal of Vascular and Interventional Radiology : JVIR·András Kónya
Aug 20, 2005·Nephrology·S Y Chan, W K Y Chan
Dec 27, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jarrod M WilliamsJohn J Bissler
Feb 13, 2007·Acta chirurgica Belgica·D Mantas, A Papachristodoulou
Jul 20, 2007·Journal of Clinical Ultrasound : JCU·Anand B GaikwadAbhaykumar S Kothari
Feb 15, 2008·The American Journal of Emergency Medicine·Li Wei HaoShin-Han Tsai

❮ Previous
Next ❯

Citations

Feb 5, 2013·Current Urology Reports·Sri Sivalingam, Stephen Y Nakada
Sep 24, 2014·AJR. American Journal of Roentgenology·Avinash MedsingeErnesto Santos
Sep 24, 2015·Cardiovascular and Interventional Radiology·Mircea CristescuFred T Lee
Nov 28, 2015·The Journal of Urology·Andrew S FlumRobert B Nadler
Dec 15, 2015·Journal of Endourology·Onder KaraRobert J Stein
Apr 27, 2012·Case Reports in Medicine·Enis Rauf CoskunerVeli Yalcin
Jan 11, 2017·Case Reports in Urology·Jacob Albersheim-CarterChristopher J Weight
Apr 19, 2017·The Journal of International Medical Research·Chengen WangYinghua Zou
Dec 9, 2016·Therapeutic Advances in Urology·John J Bissler, John C Kingswood
Jul 18, 2014·Fukushima Journal of Medical Science·Hitomi SekineMitsuaki Hosoya
Dec 21, 2017·Cardiovascular and Interventional Radiology·Timothy E Murray, Michael J Lee
Mar 17, 2017·Current Urology Reports·Ryan M Kiefer, S William Stavropoulos
Aug 27, 2019·Journal of Clinical Imaging Science·Sreeja Sanampudi, Driss Raissi
Apr 4, 2021·Medicina·Fabio Pozzi MucelliMaria A Cova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.